Johnson & Johnson Bankruptcy Trial Underway in Texas Over Proposed $10B Talcum Powder Settlement Deal
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
DOJ Calls J&J Talcum Powder Cancer Lawsuit Bankruptcy Filing “Textbook Example of Bad Faith” U.S. Trustee tells Texas Bankruptcy Judge that there is no effective difference between this plan and the two previously rejected Johnson & Johnson talcum powder bankruptcy filings. October 25, 2024 Irvin Jackson Add Your Comments The U.S. Department of Justice has come out in opposition to a recent bankruptcy filing by Johnson & Johnson, which the company is attempting to use to resolve tens of thousands of talcum powder lawsuits brought by women diagnosed with ovarian cancer, by employing a controversial tactic known as the “Texas Two-Step.” The manufacturer currently faces about 62,000 Baby Powder lawsuits and Shower-to-Shower lawsuits filed by women nationwide, who say they developed ovarian cancer after years of using Johnson & Johnson’s talc-based products on their genitals. The litigation has been ongoing since 2016, following studies linking ovarian cancer to talc use, and the discovery of asbestos in talcum powder products sold by the company for years. Despite several massive verdicts returned in early trial dates, including billions awarded to women with ovarian cancer from talcum powder, Johnson & Johnson has failed to negotiate direct settlements to resolve claims. Instead, the company has made several attempts to force the resolution of all current and future lawsuits through the U.S. bankruptcy system. Talcum Powder Texas Two-Step Last month, as part of an $8 billion talcum powder lawsuit settlement offer, Johnson & Johnson created a new subsidiary, Red River Talc, LLC., which then filed for Chapter 11 bankruptcy protection in U.S. Bankruptcy Court for the Southern District of Texas. Johnson & Johnson’s filing made the newly created subsidiary liable for the company’s failure to warn about the link between talcum powder and ovarian cancer for decades. This tactic is known as the Texas Two-Step, which results in whatever assets the parent company assigns to the newly-created, sacrificial subsidiary being all that its debtors and litigation plaintiffs are able to recover. This artificially caps the financial damage to the parent company, and can result in plaintiffs recovering just pennies on the dollar of what they are truly owed in damages. The tactic has been heavily criticized by legal experts, judges, and now, the Justice Department. This is Johnson & Johnson’s third attempt at resolving the talcum powder cancer litigation through bankruptcy. The previous two bankruptcy filings, which have delayed additional trials in the litigation for years, were thrown out after federal judges determined the company faced no real financial distress. This time, the company has filed in Texas, the state for which this bankruptcy tactic gets its name, even though Johnson & Johnson is headquartered in New Jersey. Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION On October 21, Kevin Epstein, the United States Department of Justice (DOJ) Trustee representing the Texas region, filed a motion to dismiss (PDF) the latest talcum powder lawsuit bankruptcy filing. The motion admonishes the manufacturer for its third attempt at an illegitimate use of the U.S. bankruptcy system. “Although its basic strategy is unchanged, J&J has caused this case to be filed under the name of a new shell entity and in a different district, all in an apparent effort to evade the bad faith findings entered in the previous cases,” the U.S. government argues. “Taken as a whole, J&J’s tactics are a textbook example of bad faith. The Debtor itself has no need for bankruptcy relief and it had no valid restructuring purpose when it filed its bankruptcy petition. Furthermore, there is no legitimate purpose in allowing the Debtor to remain in bankruptcy while it pursues a futile strategy, designed to benefit a non-debtor, J&J, that cannot lead to a confirmable plan of reorganization.” The filing lays out the previous failed attempts, repeatedly using the term “bad faith” to describe the company’s actions, and noting that this latest filing should fail for the very same reasons. Epstein notes that the only difference this time is that Red River has less liability, because Johnson & Johnson didn’t need to include talcum powder asbestos mesothelioma lawsuits, which have almost all been settled or otherwise resolved. “Although it involves a nominally different debtor, the Debtor’s case is in all relevant respects a repackaged version of the two dismissed LTL cases, which J&J has now caused to be filed in a different circuit in hopes of relitigating the issue of bad faith,” the motion to dismiss states. “This Court should not permit J&J and the Debtor to evade the rulings of another federal court in this manner.” Talcum Powder Lawsuit Bankruptcy Filing Delays Given common questions of fact and law raised in the complaints, talcum powder cancer lawsuits filed in federal court have been centralized in the U.S. District Court for the District of New Jersey since 2016. The litigation was previously assigned to U.S. District Judge Freeda Wolfson, but was ultimately reassigned to U.S. District Judge Matthew Shipp after her retirement a few years ago. If the court grants the DOJ’s motion to dismiss this latest bankruptcy filing, the litigation will return, for a third time, to that court for resolution. While a number of state court talcum powder lawsuits have resulted in massive verdicts, no federal trials have yet been held. Judge Shipp previously scheduled the first federal bellwether trial to begin in December 2024, which would be closely watched to gauge how juries may respond to evidence and testimony that will be repeated throughout the litigation if a global settlement is not reached. However, Johnson & Johnson’s continuous use of bankruptcy filings has prolonged the litigation process and may cause a further postponement of any planned trial date. The company and its subsidiaries have repeatedly requested that the litigation be halted while bankruptcy plans are under consideration, a tactic that could extend these delays if the proceedings are successfully stayed again. Attorneys for the plaintiffs have pointed out that many of the women they represent have either died or are in declining health as these delays prevent them from having their day in court. Tags: Asbestos, Baby Powder, Bankruptcy, Cancer, Johnson & Johnson, Ovarian Cancer, Shower to Shower, Talcum Powder Image Credit: Shutterstock More Talcum Powder Lawsuit Stories Johnson & Johnson Bankruptcy Trial Underway in Texas Over Proposed $10B Talcum Powder Settlement Deal February 21, 2025 3,500 New Talcum Powder Cancer Lawsuits Set To Be Filed in UK February 6, 2025 Judge Urged To Reject J&J’s 3rd Talcum Powder Lawsuit Bankruptcy Deal January 30, 2025 1 Comments Sharon October 28, 2024 It’s a shame that this has gone on for so long. The women that’s fighting the cancer could use the money to help in their care . J&J is getting richer and richer. My mother died and she had stage 4 ovarian cancer and the pain she went through. I’m sick of the game J&j is playing Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: today) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)FDA Hair Relaxer Formaldehyde Ban Uncertain After All Pending Regulations Frozen: NBC Reports (01/24/2025) Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: yesterday) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025) Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)
Johnson & Johnson Bankruptcy Trial Underway in Texas Over Proposed $10B Talcum Powder Settlement Deal February 21, 2025
Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: today) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)FDA Hair Relaxer Formaldehyde Ban Uncertain After All Pending Regulations Frozen: NBC Reports (01/24/2025)
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: yesterday) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025)
Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)